<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR39">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Martin-Loeches</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Dale</surname>
    <given-names>GE</given-names>
   </name>
   <name>
    <surname>Torres</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Murepavadin: a new antibiotic class in the pipeline</article-title>
  <source>Expert Rev Anti-Infect Ther</source>
  <year>2018</year>
  <volume>16</volume>
  <issue>4</issue>
  <fpage>259</fpage>
  <lpage>268</lpage>
  <pub-id pub-id-type="doi">10.1080/14787210.2018.1441024</pub-id>
  <pub-id pub-id-type="pmid">29451043</pub-id>
 </element-citation>
</ref>
